Discovery and development of antibody therapies : Webinar Kumar Jeetendra | October 2, 2021 Neutralizing antibodies (nAbs) against SARS-CoV-2 represent a promising option for treating COVID-19. Screening a large and diverse antibody phage library has allowed for the rapid discovery of anti-SARS-CoV-2 nAbs. In this expert webinar, find out how high-throughput epitope binning and mapping using using label-free biolayer interferometry (BLI) detection and advanced flow cytometry systems has enabled …
